Table 4. Means (and Standard Deviations) of EQ and TMS in the Three Prevention Conditions at Randomization and 8 Weeks Later.
| Time 2 (Randomization) | Time 3 (8 weeks post randomization) | |
|---|---|---|
| Experiences Questionnaire - Rumination | ||
| Medication (N=17) | 19.12 (2.83) | 19.05 (3.36) |
| Placebo (N=15) | 19.53 (2.20) | 19.33 (2.66) |
| MBCT (N=15) | 17.40 (4.10) | 17.73 (3.91) |
| Experiences Questionnaire – Wider Experiences | ||
| Medication (N=17) | 34.82 (6.09) | 34.35 (5.80) |
| Placebo (N=15) | 34.92 (7.65) | 30.80 (8.86) |
| MBCT (N=15) | 32.25 (6.95) | 37.21 (7.83)* |
| Toronto Mindfulness Scale - Curiosity | ||
| Medication (N=14) | 13.33 (4.3) | 11.07 (4.5) |
| Placebo (N=15) | 11.61 (5.5) | 10.00 (7.1) |
| MBCT (N=18) | 9.93 (6.8) | 13.20 (7.0) |
| Toronto Mindfulness Scale - Decentering | ||
| Medication (N=14) | 16.73 (3.8) | 14.07 (5.4) |
| Placebo (N=15) | 12.44 (6.1) | 12.00 (6.8) |
| MBCT (N=18) | 13.53 (8.2) | 19.67 (5.2)* |
Note.
*
p < .05, one-way ANOVA on standardized residualized change scores for the four subscales of the TMS and EQ by treatment group followed by post-hoc Tukey's HSD tests.